“…The role of nonclassical GPCR signaling via SMO in human pathologies is less clearly understood (Arensdorf, Marada, & Ogden, 2016; Qi et al, 2019). Le reported that bi‐allelic variants of SMO in human cause a broad spectrum of developmental anomalies: gelastic epilepsy, hypothalamic hamartoma, dysmorphic facial features and postaxial polydactyly and so forth, due to abnormal Hh signaling (Le et al, 2020). However, the heptahelical domain is the frequent target for recurrent activating mutations in cancer and somatic mosaic mutations in malformation syndromes, such as Curry‐Jones (Ayers and Thérond, 2010; Lam et al, 1999; Taipale et al, 2000; Twigg et al, 2016; Xie et al, 1998), while variation within the remaining domains characteristic of the GPCR superfamily are less frequently observed.…”